Skip to main content
. 2021 May 4;13(5):654. doi: 10.3390/pharmaceutics13050654
Dox@pVP-AuNPs doxorubicin loaded povidone coated gold nanoparticles
5FU 5-fluorouracil
AAM acrylamide
Ag-NPs silver nanoparticles
Amph-pVP amphiphilic poly-N-vinylpyrrolidone
Au-NPs gold nanoparticles
AuPd@pVP NP povidone coated gold-palladium nanoparticles
BTZ bortezomib
CDDP cis-diamminedichloroplatinum II
CTAB cetyl trimethylammonium bromide
Cur curcumin
DDSs drug delivery systems
DEAEMA 2-(diethylamino)ethyl methacrylate
FA–CurAu-PVP NPs folate–curcumin-loaded gold–polyvinylpyrrolidone nanoparticles
Gd2O3 NPs gadolin oxide nanoparticles
GEF gefitnib
GO-NPs graphene oxide nanoparticles
HPMC hydroxypropyl methylcellulose
HPβCD hydroxypropyl-β-cyclodextrin
LCST lower critical solution temperature
NaBH4 sodium borohydride
NAC N-acetyl-l-cysteine
NC nanocapsules
NE nanoemulsion
NETs neutrophil extracellular traps
NIPAAm/NVP poly(N-isopropylacrylamide-co-N-vinylpyrrolidon
NVP 1-vinyl-2-pyrrolidone
PEO poly(ethylene oxide)
PEO-b-P2VP 2-vinyl pyridine poly(ethylene oxide)-b-poly(2-vin(2-vinyl pyridine
PLGA-H polylactide-co-glycolide
PLGA-PEG polylactide-co-glycolide-co-polyethylenglycol
PTT photothermal therapy
pVP poly (N-vinyl pyrrolidone)
pVP-I povidone iodine
pVP-Ag-NPs povidone coated silver nanoparticles
QSR quercetin
RAFT the reversible addition–fragmentation chain-transfer polymerization
SAS supercritical antisolvent process
THP-1 human monocytic cell line